{
    "ticker": "NMRA",
    "name": "Nemaura Medical, Inc.",
    "description": "Nemaura Medical, Inc. is a medical technology company focused on the development of advanced glucose monitoring solutions and other innovative health technologies. Founded in 2011, the company is dedicated to improving the quality of life for patients with diabetes and related conditions through its proprietary non-invasive glucose monitoring systems. Nemaura's flagship product, the sugarBEAT\u00ae, is a non-invasive continuous glucose monitoring device designed to provide users with real-time glucose readings without the need for finger pricks or invasive sensors. In addition to glucose monitoring, Nemaura is exploring applications in various therapeutic areas, including weight management and the management of other chronic conditions. The company's mission is to empower patients to take control of their health and well-being through user-friendly and effective monitoring solutions. Nemaura is committed to research and development, with a focus on integrating digital health technologies and data analytics to enhance patient engagement and outcomes. As the global diabetes epidemic continues to rise, Nemaura Medical, Inc. is positioned to play a significant role in transforming diabetes management and improving the lives of millions of patients worldwide.",
    "industry": [
        "Medical Technology",
        "Healthcare"
    ],
    "headquarters": "Loughborough, United Kingdom",
    "founded": "2011",
    "website": "https://www.nemauramedical.com",
    "ceo": "Dr. Faz Chowdhury",
    "social_media": {
        "twitter": "https://twitter.com/NemauraMedical",
        "linkedin": "https://www.linkedin.com/company/nemaura-medical/"
    },
    "investor_relations": "https://www.nemauramedical.com/investor-relations",
    "key_executives": [
        {
            "name": "Dr. Faz Chowdhury",
            "position": "CEO"
        },
        {
            "name": "Michael O'Rourke",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Glucose Monitoring",
            "products": [
                "sugarBEAT\u00ae"
            ]
        },
        {
            "category": "Health Management",
            "products": [
                "Weight Management Solutions"
            ]
        }
    ],
    "seo": {
        "meta_title": "Nemaura Medical, Inc. | Innovative Glucose Monitoring Solutions",
        "meta_description": "Explore Nemaura Medical, Inc., a leader in non-invasive glucose monitoring technology. Discover the sugarBEAT\u00ae device and learn about our commitment to improving diabetes management.",
        "keywords": [
            "Nemaura Medical",
            "Glucose Monitoring",
            "sugarBEAT",
            "Non-invasive Diabetes Solutions",
            "Health Technology"
        ]
    },
    "faq": [
        {
            "question": "What is Nemaura Medical known for?",
            "answer": "Nemaura Medical is known for its innovative non-invasive glucose monitoring solutions, particularly the sugarBEAT\u00ae device."
        },
        {
            "question": "Who is the CEO of Nemaura Medical?",
            "answer": "Dr. Faz Chowdhury is the CEO of Nemaura Medical, Inc."
        },
        {
            "question": "Where is Nemaura Medical headquartered?",
            "answer": "Nemaura Medical is headquartered in Loughborough, United Kingdom."
        },
        {
            "question": "What products does Nemaura Medical offer?",
            "answer": "Nemaura Medical offers the sugarBEAT\u00ae glucose monitoring device and solutions for weight management."
        },
        {
            "question": "When was Nemaura Medical founded?",
            "answer": "Nemaura Medical was founded in 2011."
        }
    ],
    "competitors": [
        "DEXCOM",
        "GLOBE",
        "OMRON"
    ],
    "related_stocks": [
        "MDGL",
        "CNC",
        "MNMD",
        "RMD"
    ]
}